HomeBREAKING NEWS Launch Delayed as FDA Red Flags Emergency Use Authorisation of Bharat Biotech’s Covaxin: Report June 11, 2021 Share Facebook Twitter Pinterest WhatsApp The phase 3 data is crucial for the company, as only with those results can the company seek emergency approval from the World Health Organisation. Previous article‘Law Will be Meaningless if…’ India Welcomes Pak Move on Kulbhushan Jadhav But Has Some RidersNext articleExternal Affairs Minister Jaishankar Holds Meeting with India’s Envoys to Gulf Nations Similar Articles Lakhimpur Kheri: Viral Video Shows Farmers Being Run Over by SUV, Oppn Questions Union Minister’s Claims BREAKING NEWS - October 5, 2021 The 29-second clip, which also shows another vehicle following the SUV, has raised questions on the version of the incident by Union minister Ajay... Karnataka: 3 Dead After Drinking Contaminated Water, 108 Show Similar Symptoms BREAKING NEWS - October 5, 2021 A total of six people have died in the last five weeks but the authorities have been able link just three of the deaths... Most Popular AMPC reforms: BJP digs out Siddaramaiah’s old letter India UAE Grow Bilateral Trade Amidst Worldwide Geopolitical Shifts Author Amish on why Bollywood doesn’t adapt ancient Sanskritic texts into films